Charles E. Moore

Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Part of Viatris, Inc., Mylan Bertek Pharmaceuticals, Inc. is a company that manufactures and markets pharmaceutical products. The company is based in Research Triangle Park, NC.

ZS Genetics, Inc. develops third-generation deoxyribonucleic acid sequencing platform. It develops a technology platform for directly creating the images of individual deoxyribonucleic acid or ribonucleic acid molecules. The firm offers a single molecule sequencer based on annular dark-field scanning transmission electron microscopy. The company was founded by William R. Glover III and Thomas D. Abert in 2003 and is headquartered in Wakefield, MA.

Putney, Inc. operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets. It offers human-approved generic drugs such as ampicillin sodium for injection, cefpodoxime proxetil tablets and amoxicillin trihydrate capsules. The firm also provides injectables, carprofen caplets and dermatological therapeutics. The company was founded by Jean Hoffman in 2006 and is headquartered in Portland, ME.

Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA.

Lightstone Group creates software for logistics and supply-chain decision support businesses. The company is headquartered in Mineola, NY

Sanitas AB manufactures pharmaceutical products. The company's main activities include manufacture and sale of carious generic medicine, development of new products, and toll manufacturing. Its products are divided into two categories namely Over the Counter and Prescription Products. Its Over the Counter Products consist of acetylsalicylic acid, alkostop, aprotinine, ascorbic acid, and argentum sulfathiazole. The firm's Prescrition Products include acetaminophen, paracetamol, coffein, aciclovirum natrium, aminophylline, and argentum sulfathiazole. The company was founded in 1922 and is headquartered in Kuanas, Lithuania.

Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA.

IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL.

Dartmouth-Hitchcock Medical Center operates a general medical hospital. It is a nonprofit academic health system. The firm health care professionals offer clinical, education, research, nursing, specialty referrals and resource services. The company was founded in 1893 and is headquartered in Lebanon, NH.

Sanitas Pharmaceuticals Ltd. manufactures and markets Pharmaceutical products. The company is headquartered in Brampton, Canada

West-Ward Pharmaceutical Corp. provides generic prescription medication services. It offers both oral solid and injectable pharmaceuticals to chain stores, wholesalers, distributors, health systems and government agencies. The company is headquartered in Eatontown, US.

Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ.

Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd.